Alliance Pharma plc (LON:APH – Get Free Report) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 38.67 ($0.48) and traded as low as GBX 35.50 ($0.44). Alliance Pharma shares last traded at GBX 35.50 ($0.44), with a volume of 1,069,823 shares changing hands.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada reduced their target price on shares of Alliance Pharma from GBX 65 ($0.80) to GBX 60 ($0.74) and set an “outperform” rating for the company in a report on Wednesday, January 31st.
Read Our Latest Research Report on Alliance Pharma
Alliance Pharma Trading Up 1.4 %
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Featured Stories
- Five stocks we like better than Alliance Pharma
- What Are Dividend Challengers?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What Does a Stock Split Mean?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Learn Technical Analysis Skills to Master the Stock Market
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.